Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cleary

Showing results (201-210 of 360) with videos related to

Pageof 36
Sort By:
Diabetes|October 1, 1995
Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications TrialJ Q Purnell, S M Marcovina, J E Hokanson, et al.
Diabetes Care|July 24, 2015
Relationship of urologic complications with health-related quality of life and perceived value of health in men and women with type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Interventions and Complications (DCCT/EDIC) cohortAlan M Jacobson, Barbara H Braffett, Patricia A Cleary, et al.
The New England Journal of Medicine|November 15, 2011
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes, Ian H de Boer, Wanjie Sun, et al.
Cardiovascular Diabetology|February 12, 2016
Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetesDavid R Sell, Wanjie Sun, Xiaoyu Gao, et al.
Diabetes Care|May 2, 2009
Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/ EDIC study cohortPaul Enzlin, Raymond Rosen, Markus Wiegel, et al.
Diabetes Care|July 12, 2007
Intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification in the diabetes control and complications trialRickey E Carter, Daniel T Lackland, Patricia A Cleary, et al.
Diabetes Care|July 2, 1999
Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetesS D Sibley, J E Hokanson, M W Steffes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 16, 2012
Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and ComplicationsW H Herman, R Pop-Busui, B H Braffett, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 18, 2022
Weight gain trajectories and obesity rates in intensive and conventional treatments of type 1 diabetes from the DCCT compared with a control population without diabetesNichole E Carlson, Ken W Horton, John E Hokanson, et al.
Osteoarthritis and Cartilage|December 22, 2015
Expression of CD105 on expanded mesenchymal stem cells does not predict their chondrogenic potentialM A Cleary, R Narcisi, K Focke, et al.
Pageof 36

Showing results (201-210 of 360) with videos related to

Sort By:
Pageof 36
Diabetes|October 1, 1995
Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications TrialJ Q Purnell, S M Marcovina, J E Hokanson, et al.
Diabetes Care|July 24, 2015
Relationship of urologic complications with health-related quality of life and perceived value of health in men and women with type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Interventions and Complications (DCCT/EDIC) cohortAlan M Jacobson, Barbara H Braffett, Patricia A Cleary, et al.
The New England Journal of Medicine|November 15, 2011
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes, Ian H de Boer, Wanjie Sun, et al.
Cardiovascular Diabetology|February 12, 2016
Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetesDavid R Sell, Wanjie Sun, Xiaoyu Gao, et al.
Diabetes Care|May 2, 2009
Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/ EDIC study cohortPaul Enzlin, Raymond Rosen, Markus Wiegel, et al.
Diabetes Care|July 12, 2007
Intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification in the diabetes control and complications trialRickey E Carter, Daniel T Lackland, Patricia A Cleary, et al.
Diabetes Care|July 2, 1999
Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetesS D Sibley, J E Hokanson, M W Steffes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 16, 2012
Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and ComplicationsW H Herman, R Pop-Busui, B H Braffett, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 18, 2022
Weight gain trajectories and obesity rates in intensive and conventional treatments of type 1 diabetes from the DCCT compared with a control population without diabetesNichole E Carlson, Ken W Horton, John E Hokanson, et al.
Osteoarthritis and Cartilage|December 22, 2015
Expression of CD105 on expanded mesenchymal stem cells does not predict their chondrogenic potentialM A Cleary, R Narcisi, K Focke, et al.
Pageof 36